841 related articles for article (PubMed ID: 11478140)
1. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
Tsukamoto S; Akaza H
Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
[TBL] [Abstract][Full Text] [Related]
2. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
3. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
4. Endocrine therapy for prostate cancer.
Damber JE
Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
[TBL] [Abstract][Full Text] [Related]
5. [Keyrole of endocrinology in the victory against prostate cancer].
Labrie F
Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
[TBL] [Abstract][Full Text] [Related]
6. [New development of endocrine therapy in prostate cancer].
Naito S
Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018
[TBL] [Abstract][Full Text] [Related]
7. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
8. [First line therapy in the treatment of metastatic prostate cancer].
Sakai H; Kanetake H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
[TBL] [Abstract][Full Text] [Related]
9. Combined androgen blockade: the gold standard for metastatic prostate cancer.
McLeod DG; Crawford ED; DeAntoni EP
Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789
[TBL] [Abstract][Full Text] [Related]
10. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
11. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
Scherr DS; Pitts WR
J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
[TBL] [Abstract][Full Text] [Related]
12. Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer.
Youssef E; Tekyi-Mensah S; Hart K; Bolton S; Forman J
Am J Clin Oncol; 2003 Oct; 26(5):e119-23. PubMed ID: 14528085
[TBL] [Abstract][Full Text] [Related]
13. [Hormone therapy for prostate cancer].
Théodore C
Bull Cancer; 2004 Jan; 91(1):69-74. PubMed ID: 14975807
[TBL] [Abstract][Full Text] [Related]
14. Endocrine treatment of prostate cancer: standard treatment and new perspectives.
Boccardo F; Pace M
In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].
Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1996 Oct; 42(10):821-7. PubMed ID: 8951482
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate].
Boccon-Gibod L
Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748
[No Abstract] [Full Text] [Related]
18. Advanced prostate cancer. Hormonal treatment.
de la Haba-RodrÃguez J
Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
[No Abstract] [Full Text] [Related]
19. [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer].
Akaza H; Hirao Y; Labrie F; Soloway MS
Hinyokika Kiyo; 2003 Dec; 49(12):771-7. PubMed ID: 14978964
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation therapy for prostate cancer: current status and future prospects.
Miyamoto H; Messing EM; Chang C
Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]